Related references
Note: Only part of the references are listed.High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome
Martine E. D. Chamuleau et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Cancer vaccines: Moving beyond current paradigms
Jeffrey Schlom et al.
CLINICAL CANCER RESEARCH (2007)
GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis
Kanji Uchida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A clinical development paradigm for cancer vaccines and related biologics
Axel Hoos et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia
Bruce D. Cheson et al.
BLOOD (2006)
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
Y Oka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants
JM Siehl et al.
ANNALS OF HEMATOLOGY (2004)
Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity
V Mailander et al.
LEUKEMIA (2004)
WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome
D Cilloni et al.
ACTA HAEMATOLOGICA (2004)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Effects of granulocyte-macrophage colony-stimulating factor and foreign helper protein as immunologic adjuvants on the T-cell response to vaccination with tyrosinase peptides
C Scheibenbogen et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells
CL Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers
Y Oji et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Immunologic monitoring of cancer vaccine therapy: Results of a workshop sponsored by the Society for Biological Therapy
U Keilholz et al.
JOURNAL OF IMMUNOTHERAPY (2002)
Share Paper
